Quick Answer
AEON Biopharma, Inc. reported Research And Development Expense of $4.09 million for the year ending 2025.
- AEON Biopharma, Inc. showed a decrease of -71.1% in Research And Development Expense from 2024 to 2025.
- This data is from AEON Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2022 to 2025), AEON Biopharma, Inc.'s Research And Development Expense has declined by 88.2%.
- Historical annual values: Fiscal year 2025: $4.09 million | Fiscal year 2024: $14.18 million | Fiscal year 2022: $34.75 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: